Affordable Access

Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.

Authors
  • Williams, D'Nyce L
  • Newman, Daniel R
  • Ballagh, Susan A
  • Creinin, Mitchell D
  • Barnhart, Kurt
  • Weiner, Debra H
  • Bell, April J
  • Jamieson, Denise J
Type
Published Article
Journal
Sexually Transmitted Diseases
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Dec 01, 2007
Volume
34
Issue
12
Pages
977–984
Identifiers
PMID: 18080349
Source
Medline
License
Unknown

Abstract

Acidform and BufferGel compared to KY Jelly, when used with diaphragm daily for 14 days, appeared to be safe and acceptable in a small study of low-risk abstinent women.

Report this publication

Statistics

Seen <100 times